Identification of miR-145 as a key regulator of the pigmentary process

Area of Science:

• Molecular Biology
• Dermatology
• Genetics

Background:

• Current hyperpigmentation treatments lack efficacy and cause side effects.
• MicroRNA (miRNA)-based therapies offer targeted gene regulation for melanogenesis.
• Identifying specific miRNAs involved in pigmentation is crucial for developing novel treatments.

Purpose of the Study:

• To identify miRNAs that regulate the pigment production process (melanogenesis).
• To investigate the functional role of identified miRNAs in melanocytes.
• To explore miRNA-based therapeutic strategies for hyperpigmentation.

Main Methods:

• Performed miRNA profiling on mouse melanocytes treated with forskolin and simulated solar UV (ssUV) irradiation.
• Modulated miR-145 expression (overexpression and downregulation) in melan-a cells.
• Utilized luciferase reporter assays to confirm direct gene targeting.
• Analyzed melanosome distribution and pigmentation in human melanocytes via immunofluorescence.

Main Results:

• Identified 16 differentially expressed miRNAs, with a significant 15-fold downregulation of miR-145.
• Modulating miR-145 affected the expression of key melanogenesis genes (Sox9, Mitf, Tyr, Trp1, Myo5a, Rab27a, Fscn1).
• Confirmed direct targeting of Myo5a by miR-145 and observed melanosome perinuclear accumulation and hypopigmentation in transfected cells.

Conclusions:

• Established an miRNA signature linked to forskolin and ssUV treatments.
• Demonstrated miR-145's critical role in regulating melanogenesis through its impact on pigmentation genes.
• Highlighted miR-145 as a potential therapeutic target for managing hyperpigmentation disorders.